Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety, tolerability and pharmacokinetic
characteristics of BIII 890 after intravenous infusion in acute ischemic stroke patients.